» Articles » PMID: 3514676

Partial Factor IX Protein in a Pedigree with Hemophilia B Due to a Partial Gene Deletion

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1986 Apr 1
PMID 3514676
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

A partial gene product was identified in a pedigree with hemophilia B due to a partial deletion of the Factor IX gene (Chen, S.-H.,S. Yoshitake, P.F. Chance, G.L. Bray, A.R. Thompson, C.R. Scott, and K. Kurachi, 1985, J. Clin. Invest., 76:2161-2164). Levels of this mutant protein in plasma of affected family members studied ranged from 24 to 36 ng/ml (0.6-0.9 U/dl or percent of normal) by a solid-phase immunoassay which is sensitive and specific for the calcium-dependent conformation of human Factor IX. No Factor IX antigen could be detected in patients' plasmas by a non-calcium-requiring monoclonal anti-Factor IX antibody (less than 2 ng/ml). The unconcentrated urine from the five affected family members and four obligate heterozygotes the five affected family members and four obligate heterozygotes tested contained calcium-dependent Factor IX antigen levels ranging from 64 to 160 ng/ml (1.6-4.0 U/dl) and from 10 to 68 ng/ml (0.25-1.7 U/dl), respectively. Of nine normal volunteers screened, three had detectable calcium-dependent antigen in unconcentrated first morning-voided urines with 9.6-16.8 ng/ml (0.24-0.42 U/dl), while the remaining six had detectable urinary antigen only after a 10-fold concentration. Abnormal and normal urinary Factor IX antigen species were concentrated, immunoaffinity purified, electrophoresed, immunoblotted, and distinguished by autoradiography after incubation with 125I-polyclonal calcium-requiring anti-Factor IX. After reducing purified or concentrated samples, a single abnormal 36,000-mol-wt band was identified in the urines from the four affected family members and four obligate heterozygotes tested. Electrophoresis of the reduced urinary Factor IX antigen from the one normal subject tested showed a broad 15,000-20,000-mol-wt band. This normal band was smaller than the species in patients' urines, and was seen as a minor component in the samples from the heterozygotes. No abnormal antigen could be detected in urine from the two other female family members tested. Thus, abnormal urinary Factor IX antigen represents a marker for the presence of the hemophilic Factor IX gene in this family.

Citing Articles

Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients.

Matthews R, Anson D, Peake I, Bloom A J Clin Invest. 1987; 79(3):746-53.

PMID: 3029178 PMC: 424186. DOI: 10.1172/JCI112880.


Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.

Schach B, Yoshitake S, Davie E J Clin Invest. 1987; 80(4):1023-8.

PMID: 2821070 PMC: 442341. DOI: 10.1172/JCI113155.

References
1.
Kessler S . Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A. J Immunol. 1975; 115(6):1617-24. View

2.
Weber K, Osborn M . The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969; 244(16):4406-12. View

3.
Towbin H, Staehelin T, Gordon J . Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979; 76(9):4350-4. PMC: 411572. DOI: 10.1073/pnas.76.9.4350. View

4.
Smith K, Thompson A . Labeled factor IX kinetics in patients with hemophilia-B. Blood. 1981; 58(3):625-9. View

5.
Thompson A . Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients. Thromb Haemost. 1982; 48(1):27-32. View